These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 16449486)
21. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. Pallanti S; Quercioli L; Sood E; Hollander E J Clin Psychiatry; 2002 Jul; 63(7):559-64. PubMed ID: 12143910 [TBL] [Abstract][Full Text] [Related]
22. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). Pallanti S; DeCaria CM; Grant JE; Urpe M; Hollander E J Gambl Stud; 2005; 21(4):431-43. PubMed ID: 16311876 [TBL] [Abstract][Full Text] [Related]
23. A double-blind, placebo-controlled trial of topiramate for pathological gambling. Berlin HA; Braun A; Simeon D; Koran LM; Potenza MN; McElroy SL; Fong T; Pallanti S; Hollander E World J Biol Psychiatry; 2013 Mar; 14(2):121-8. PubMed ID: 21486110 [TBL] [Abstract][Full Text] [Related]
24. Demographic and clinical features of 131 adult pathological gamblers. Grant JE; Kim SW J Clin Psychiatry; 2001 Dec; 62(12):957-62. PubMed ID: 11780876 [TBL] [Abstract][Full Text] [Related]
26. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Gual A; He Y; Torup L; van den Brink W; Mann K; Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
28. Comorbidity of impulse control disorders in pathological gamblers. Grant JE; Kim SW Acta Psychiatr Scand; 2003 Sep; 108(3):203-7. PubMed ID: 12890275 [TBL] [Abstract][Full Text] [Related]
29. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606 [TBL] [Abstract][Full Text] [Related]
30. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161 [TBL] [Abstract][Full Text] [Related]
31. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Mann K; Bladström A; Torup L; Gual A; van den Brink W Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314 [TBL] [Abstract][Full Text] [Related]
32. Pathological gambling: focusing on the addiction, not the activity. Tamminga CA; Nestler EJ Am J Psychiatry; 2006 Feb; 163(2):180-1. PubMed ID: 16449466 [No Abstract] [Full Text] [Related]
33. Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study. Lahti T; Halme JT; Pankakoski M; Sinclair D; Alho H Psychopharmacol Bull; 2010; 43(3):35-44. PubMed ID: 21150845 [TBL] [Abstract][Full Text] [Related]
34. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. Dannon PN; Lowengrub K; Musin E; Gonopolski Y; Kotler M J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845 [TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. Grant JE; Odlaug BL; Chamberlain SR; Potenza MN; Schreiber LR; Donahue CB; Kim SW J Clin Psychiatry; 2014 Jan; 75(1):39-45. PubMed ID: 24345329 [TBL] [Abstract][Full Text] [Related]
36. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose. Kaplan JL; Marx JA; Calabro JJ; Gin-Shaw SL; Spiller JD; Spivey WL; Gaddis GM; Zhao N; Harchelroad FP Ann Emerg Med; 1999 Jul; 34(1):42-50. PubMed ID: 10381993 [TBL] [Abstract][Full Text] [Related]
37. The use of nalmefene for intrathecal opioid-associated nausea in postpartum patients. Ward RC; Lawrence RL; Hawkins RJ; DiChiara SE; Biegner AR; Vacchiano CA AANA J; 2002 Feb; 70(1):57-60. PubMed ID: 11887546 [TBL] [Abstract][Full Text] [Related]
38. Sertraline treatment of pathological gambling: a pilot study. Saiz-Ruiz J; Blanco C; Ibáñez A; Masramon X; Gómez MM; Madrigal M; Díez T J Clin Psychiatry; 2005 Jan; 66(1):28-33. PubMed ID: 15669885 [TBL] [Abstract][Full Text] [Related]
39. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130 [TBL] [Abstract][Full Text] [Related]